Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 527-531

  Fuszek, Peter ^a   Horvath, Henrik Csaba ^a   Speer, Gabor ^a   Papp, Janos ^a   Haller, Petra ^a   Fischer, Simon ^a   Halasz, Judit ^a   Jaray, Balazs ^a   Szekely, Eszter ^a   Schaff, Zsuzsanna ^a   Papp, Andras ^a   Bursics, Attila ^a   Harsanyi, Laszlo ^a   Lukovich, Peter ^a   Kupcsulik, Peter ^a   Hitre, Erika ^b   Lakatos, Peter Laszlo ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Cancer screening; Colorectal cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SCREENING; COLORECTAL CANCER; FEMALE; GENDER; HUMAN; HUNGARY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HUNGARY; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; SEX FACTORS;

EID: 32144445460     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
2. Otto S and Kasler M: Cancer mortality and incidence in Hungary in relation to international data. Magy Onkol 46: 111-117, 2002.
3. Chien C, Morimoto LM, Tom J and Li CI: Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 104: 629-639, 2005.
4. Sariego J, Byrd ME, Kerstein M, Sano C and Matsumoto T: Changing patterns in colorectal carcinoma: a 25-year experience. Am Surg 55: 686-691, 1992.
5. Miller A, Gorska M and Bassett M: Proximal shift of colorectal cancer in the Australian Capital Territory over 20 years. Aust NZ J Med 30: 221-225, 2000.
6. Ponz de Leon M, Marino M, Benatti P, Rossi G, Menigatti M, Pedroni M, Di Gregorio C, Losi L, Borghi F, Scarselli A, Ponti G, Roncari B, Zangardi G, Abbati G, Ascari E and Roncucci L: Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 15: 940-946, 2004.
7. Vassilopoulos PP, Kelessis N, Plataniotis G, Gondikakis E and Galanos A: Colorectal cancer trends by anatomic sites, age and staging. A twenty-year study of 1412 Greek cases. Anticancer Res 20: 4773-4776, 2000.
8. Cucino C, Buchner AM and Sonnenberg A: Continued rightward shift of colorectal cancer. Dis Colon Rectum 45: 1035-1040, 2002.
9. Cheng X, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, Carozza SE and Greenlee R: Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 92: 2547-2554, 2001.
10. Takada H, Ohsawa T, Iwamoto S, Yoshida R, Nakano M, Imada S, Yoshioka K, Okuno M, Masuya Y, Hasegawa K, Kamano N, Hioki K, Muto T and Koyama Y: Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45: 1249-1254, 2002.
11. Ikeda Y, Koyanagi N, Mori M, Minagawa S, Toyomasu T, Ezaki T, Tateishi H and Sugimachi K: Tumor stage in the proximal colon under conditions of a proximal shift of colorectal cancer with age. Hepatogastroenterology 45: 1535-1538, 1998.
12. Dray X, Boutron-Ruault MC, Bertrais S, Sapinho D, Benhamiche-Bouvier AM and Faivre J: Influence of dietary factors on colorectal cancer survival. Gut 52: 868-873, 2003.
13. Fuszek P, Lakatos P, Tabak A, Papp J, Nagy Z, Takacs I, Horvath HC, Lakatos PL and Speer G: Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 10: 1890-1892, 2004.
14. Potter JD, Slattery ML, Bostick RM and Gapstur SM: Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545, 1993.
15. Jubelirer SJ, Wells JB, Emmett M and Broce M: Incidence of colorectal cancer in West Virginia from 1993-1999: an update by gender, age, subsite and stage. WV Med J 99: 182-186, 2003.
16. Mostafa G, Matthews BD, Norton HJ, Kercher KW, Sing RF and Heniford BT: Influence of demographics on colorectal cancer. Am Surg 70: 259-264, 2004.
17. Kotake K, Honjo S, Sugihara K, Kato T, Kodaira S, Takahashi T, Yasutomi M, Muto T and Koyama Y: Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46(10 Suppl): S32-43, 2003.
18. Ji BT, Devesa SS, Chow WH, Jin F and Gao YT: Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev 7: 661-666, 1998.
19. Svensson E, Grotmol T, Hoff G, Langmark F, Norstein J and Tretli S: Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis. Eur J Cancer Prev 11: 489-495, 2002.
20. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, Teramoto K, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Hamada J, Ishizu A, Ikeda H, Kondo S, Katoh H, Moriuchi T and Yoshiki T: Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124: 216-224, 2005.
21. Gervaz P, Bucher P and Morel P: Two colons - two cancers: paradigm shift and clinical implications. J Surg Oncol 88: 261-266, 2004.
22. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA and Orntoft TF: Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384, 2005.
23. Ouyang DL, Chen JJ, Getzenberg RH and Schoen RE: Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol 100: 1393-1403, 2005.
24. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM and Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328: 1365-1371, 1993.
25. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD and Mangham CM: Randomised controlled trial of faecal-occult-blood- screening for colorectal cancer. Lancet 348: 1472-1477, 1996.
26. Brenner H, Arndt V, Stegmaier C, Ziegler H and Sturmer T: Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages. Eur J Cancer Prev 14: 231-237, 2005.
27. Haug U and Brenner H: A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy. Cancer Epidemiol Biomarkers Prev 14: 422-428, 2005.
28. Gill S, Thomas RR and Goldberg RM: Review article: colorectal cancer chemotherapy. Aliment Pharmacol Ther 18: 683-692, 2003.
29. Parc Y, Gueroult S, Mourra N, Serfaty L, Flejou JF, Tiret E and Pare R: Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut 53: 371-375, 2004.
30. Lim SB, Jeong SY and Lee MR: Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis 19: 533-537, 2004.